Enovix (ENVX) reported a fiscal Q4 non-GAAP loss late Wednesday of $0.11 per diluted share, compared with a $0.28 loss a year earlier.
Analysts polled by FactSet expected a loss of $0.19.
Revenue for the quarter that ended Dec. 29 was $9.7 million, up from $7.4 million a year earlier. Analysts surveyed by FactSet expected $8.8 million.
The company expects a fiscal Q1 2025 non-GAAP EPS loss of $0.15 to $0.21. Analysts surveyed by FactSet expect a loss of $0.17.
The company expects Q1 sales to be between $3.5 million and $5.5 million. Analysts polled by FactSet expect $6.2 million.
Shares traded 15% lower in after-hours activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.